Artrya (ASX:AYA) is the latest Aussie biotech stock to score an FDA approval and consequent rewarding share price jump from ...

Cleerly to Present Late-Breaking Clinical Trial Results on Cardiovascular Risk in Women at ACC.25. Cleerly, the leader in ...

The signs of a dangerous blood clot can vary depending on its location. Some people may also not experience any symptoms.

And a new study now suggests those with HPV may be at an 40 percent increased risk of developing heart disease and coronary artery disease. The group of viruses is most often associated with cancer in ...

HPV infection increases cardiovascular disease risk by 40% and doubles coronary artery disease risk, adding to concerns about ...

The study shared with the American College of Cardiology combined existing evidence around an infection that will affect ...

With health outcomes significantly worse in women, Alberta researchers are pleased to see the province declare March Women's ...

More than 60 million American women have heart disease. "The statistics haven't improved enough," a women's heart doctor told ...

Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced additional investments in the company of approximately $98 million through the sale and issuance of ...

In patients with metabolic dysfunction-associated steatotic liver disease, there is increased risk for heart failure with preserved ejection fraction.

Human papillomavirus appears to increase risk for cardiovascular disease and coronary artery disease, according to a ...

People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...